Tobias S Schiergens1, Verena Hoffmann, Tamara N Schobel, Gerhard H Englert, Martin E Kreis, Wolfgang E Thasler, Jens Werner, Michael S Kasparek. 1. 1 Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, Hospital of the University of Munich, Munich, Germany 2 Department of Medical Informatics, Biometry and Epidemiology, University of Munich, Munich, Germany 3 Deutsche ILCO e.V., Bonn, Germany 4 Department of General, Visceral and Vascular Surgery, University of Berlin-Charité, Campus Benjamin Franklin, Berlin, Germany.
Abstract
BACKGROUND: Patients with permanent end ileostomy are at high risk for detrimental stomal effects on their quality of life. However, little is known about the long-term quality of life of these patients. OBJECTIVE: The purpose of this study was to assess long-term quality of life in patients with permanent end ileostomy. DATA SOURCES: Registration at the German self-help organization ILCO was used for this study. STUDY SELECTION: Selection included a cross-sectional survey of 1434 patients with permanent end ileostomy. MAIN OUTCOME MEASURES: Quality of life was assessed using the Medical Outcomes Study Short Form 36, including physical and mental component summary scores, the Gastrointestinal Quality of Life Index, and the Cleveland Global Quality of Life Index. Multivariate risk factor analysis was performed. RESULTS: A total of 783 responders were included. Indications for ileostomy included ulcerative colitis (44%), Crohn's disease (38%), and colorectal cancer (7%). Adverse effects on daily life because of stoma were reported by 72% of participants. Quality of life was significantly impaired compared with the general population on all of the summary scores and several subscales (physical component summary: 44.6 ± 10.4 (mean ± SD) vs 50.2 ± 10.2, p < 0.001; mental component summary: 47.5 ± 10.7 vs 51.5 ± 10.2, p < 0.001; Gastrointestinal Quality of Life Index: 94.4 ± 16.4 vs 126.0, p < 0.001). Stoma care problems affecting quality of life were reported by 63% of respondents. These included parastomal hernia (p < 0.001), stenosis (p = 0.003), and prolapse (p = 0.008). Vitamin B12, iron, and zinc deficiencies were also associated with diminished quality of life; in particular, vitamin B12 deficiency was associated with reduced mental and emotional quality of life. LIMITATIONS: Not all patients undergoing ileostomy in Germany are registered at ILCO, and there were many nonresponders. In addition, the inherent limitations of cross-sectional studies should be considered, including the response-shift phenomenon. CONCLUSIONS: Quality of life was markedly impaired in patients with permanent end ileostomy as compared with the general population. The main reasons were stoma-associated morbidity and nutritional deficiency syndromes. These findings highlight the importance of prevention, screening, and adequate treatment.
BACKGROUND:Patients with permanent end ileostomy are at high risk for detrimental stomal effects on their quality of life. However, little is known about the long-term quality of life of these patients. OBJECTIVE: The purpose of this study was to assess long-term quality of life in patients with permanent end ileostomy. DATA SOURCES: Registration at the German self-help organization ILCO was used for this study. STUDY SELECTION: Selection included a cross-sectional survey of 1434 patients with permanent end ileostomy. MAIN OUTCOME MEASURES: Quality of life was assessed using the Medical Outcomes Study Short Form 36, including physical and mental component summary scores, the Gastrointestinal Quality of Life Index, and the Cleveland Global Quality of Life Index. Multivariate risk factor analysis was performed. RESULTS: A total of 783 responders were included. Indications for ileostomy included ulcerative colitis (44%), Crohn's disease (38%), and colorectal cancer (7%). Adverse effects on daily life because of stoma were reported by 72% of participants. Quality of life was significantly impaired compared with the general population on all of the summary scores and several subscales (physical component summary: 44.6 ± 10.4 (mean ± SD) vs 50.2 ± 10.2, p < 0.001; mental component summary: 47.5 ± 10.7 vs 51.5 ± 10.2, p < 0.001; Gastrointestinal Quality of Life Index: 94.4 ± 16.4 vs 126.0, p < 0.001). Stoma care problems affecting quality of life were reported by 63% of respondents. These included parastomal hernia (p < 0.001), stenosis (p = 0.003), and prolapse (p = 0.008). Vitamin B12, iron, and zinc deficiencies were also associated with diminished quality of life; in particular, vitamin B12 deficiency was associated with reduced mental and emotional quality of life. LIMITATIONS: Not all patients undergoing ileostomy in Germany are registered at ILCO, and there were many nonresponders. In addition, the inherent limitations of cross-sectional studies should be considered, including the response-shift phenomenon. CONCLUSIONS: Quality of life was markedly impaired in patients with permanent end ileostomy as compared with the general population. The main reasons were stoma-associated morbidity and nutritional deficiency syndromes. These findings highlight the importance of prevention, screening, and adequate treatment.
Authors: Charlotte L Rud; Simon M D Baunwall; Palle Bager; Jens F Dahlerup; Trine L Wilkens; Anders Tøttrup; Simon Lal; Christian L Hvas Journal: Dis Colon Rectum Date: 2022-07-05 Impact factor: 4.412
Authors: Jun Woo Bong; Seok-Byung Lim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Chang Sik Yu; Jin Cheon Kim Journal: Gastroenterol Res Pract Date: 2018-06-10 Impact factor: 2.260
Authors: Felix J Hüttner; Pascal Probst; André Mihaljevic; Pietro Contin; Colette Dörr-Harim; Alexis Ulrich; Martin Schneider; Markus W Büchler; Markus K Diener; Phillip Knebel Journal: BMJ Open Date: 2020-10-15 Impact factor: 2.692
Authors: Zhi Zheng; Weitao Zhang; Chenglin Xin; Na Zeng; Mengyi Li; Xiaoye Liu; Jun Cai; Fandong Meng; Dong Liu; Jie Zhang; Jie Yin; Jun Zhang; Zhongtao Zhang Journal: Ann Transl Med Date: 2021-06
Authors: V Celentano; D P O'Leary; A Caiazzo; K G Flashman; F Sagias; J Conti; A Senapati; J Khan Journal: Tech Coloproctol Date: 2019-10-29 Impact factor: 3.781